ATX
Click for more information
4.92% 6.4¢ amplia therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-26

  1. vrs37
    437 Posts.
    lightbulb Created with Sketch. 211
    clock Created with Sketch.
    29/02/24
    15:23
    Post #: 72673578
    no I expect this is phase 2. They have already established a suitable dose of AMP to take into further trial testing so now it should be case of taking that dose and combining with Folfirinx. We’ll know if/when this study design is communicated and put on clinical trials.gov.
    ATX Price at posting: 7.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.4¢ 		Change
0.003(4.92%) 		Mkt cap ! $17.38M
Open High Low Value Volume
6.1¢ 6.6¢ 6.1¢ $28.65K 462.7K

Buyers (Bids)

No. Vol. Price($)
2 50642 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 131151 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.